
Raxbery Pharmaceuticals Private Limited
About Raxbery Pharmaceuticals Private Limited
Data last updated:
Raxbery Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the site preparation segment of the construction sector. It was incorporated on 08 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U45100KA2013PTC068988. Its GSTIN is 29AAGCR3797L1ZI (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Ravindran Peedigial (Managing Director) and Shujing Ye.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at #13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068.
As per the financials filed for FY 2021, the company reported a revenue of ₹25.5 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹50,997 (net margin -2%) and EBITDA of -₹50,732 (EBITDA margin -2%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Raxbery Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900KA2013PTC068988. The current CIN is U45100KA2013PTC068988, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U45100KA2013PTC068988 | Current |
| U74900KA2013PTC068988 | Previous |
Contact details
Raxbery Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068
- IndustryConstruction, Site Preparation
To see the full contact details of Raxbery Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raxbery Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Raxbery Pharmaceuticals Private Limited, buy the company report.
Financials of Raxbery Pharmaceuticals Private Limited
FY 2021 filings availableRaxbery Pharmaceuticals Private Limited reported revenue of ₹25.5 Lakh (down 55% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 55% fall in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹50,732 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹50,997 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | ||||
| Net Profit Margin | -2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raxbery Pharmaceuticals Private Limited, buy the company report.
Board of directors of Raxbery Pharmaceuticals Private Limited
Raxbery Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Ravindran Peedigial | Managing Director | 08 May 2013 | 13 Years 6 Months | Current |
| Shujing Ye | Director | 12 Nov 2016 | 10 Years 0 Months | Current |
Auditor
Raxbery Pharmaceuticals Private Limited is audited by KPMS & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KPMS & Associates | FY 2017 | 012090S |
Shareholding
The shareholding of Raxbery Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Raxbery Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Raxbery Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raxbery Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raxbery Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCR3797L1ZI | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Raxbery Pharmaceuticals Private Limited, buy the company report.
Recent activity
Raxbery Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Shujing Ye was appointed as Director on 12 Nov 2016.
Frequently asked questions
Raxbery Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in site preparation, within the construction industry. It was incorporated on 08 May 2013 (13+ years old) and is registered under CIN U45100KA2013PTC068988.
Raxbery Pharmaceuticals has 2 current directors:
- Manoj Ravindran Peedigial - Managing Director
- Shujing Ye - Director
The latest financial statements of Raxbery Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Raxbery Pharmaceuticals is 29AAGCR3797L1ZI, registered in Karnataka.
The CIN (Corporate Identification Number) of Raxbery Pharmaceuticals is U45100KA2013PTC068988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raxbery Pharmaceuticals was incorporated on 08 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Shujing Ye was appointed as Director on 12 Nov 2016. Vijayammal ceased to be Director on 01 Nov 2016. Lakshmi Yadla ceased to be Director on 22 Apr 2016. Raxbery Pharmaceuticals has 4 board changes on record in total.
The registered office of Raxbery Pharmaceuticals is at #13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068.
Raxbery Pharmaceuticals operates in the construction industry, in the site preparation segment.
The compliance status of Raxbery Pharmaceuticals is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.

